ATC Group: L01AX04 Dacarbazine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01AX04 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01A Alkylating agents
4 L01AX Other alkylating agents
5 L01AX04 Dacarbazine

Active ingredients in L01AX04

Active Ingredient Description
Dacarbazine

Dacarbazine is a cytostatic agent. The antineoplastic effect is due to an inhibition of cell growth which is independent of the cell cycle and due to an inhibition of DNA synthesis.

Medicines in this ATC group

Brazil (BR)

Estonia (EE)

France (FR)

Lithuania (LT)

Poland (PL)

Romania (RO)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.